Lithium iodide solution

SECTION 1
IDENTIFICATION OF THE PRODUCT AND OF THE SUPPLIER
Product Name Lithium Iodide Solution
OtherName
Manufacturer
Scancia

IN CASE OF EMERGENCY
955 av. St-Jean-Baptiste
Call CANUTEC at 613-996-6666 (24h)
Québec, Qc G2E 5J5
SECTION 2
HAZARD IDENTIFICATION
May be irritating to eyes, respiratory system and skin.
SECTION 3
COMPOSITION/INFORMATION ON INGREDIENTS
Ingredient
SECTION 4
FIRST AID MEASURES
Remove contaminated clothing, wash thoroughly before reuse.
Flush with water for at least 15 minutes occasionally lifting upper and lower eyelids.
Remove contaminated clothing and flush with water thoroughly.
Inhalation Move to fresh air. Consult doctor if symptoms persist.
Ingestion
If large amounts were swallowed, get immediate medical help. If the patient is conscious, give large quantities of water.
SECTION 5
FIREFIGHTING MEASURES
Flash Point
Extinguishing
Appropriate to surrounding fire conditions.
Protective Equipment Wear appropriate to surrounding fire conditions.
SECTION 6
ACCIDENTAL RELEASE MEASURES
Contain and recover liquid when possible. Collect liquid in an appropriate container or absorb with an inert material (e. g., vermiculite, dry sand, earth), and place in a chemical waste container. Small amounts of residue may be flushed to sewer with plenty of water.
SECTION 7
HANDLING AND STORAGE
Have an immediate availability of an eye wash in case of emergency. Store at room temperature. Protect from freezing. Keep the container tightly closed. Use good Laboratory Practice when working with any chemical whether it is considered hazardous or not.
SECTION 8
EXPOSURE CONTROLS/PERSONAL PROTECTION
SECTION 9
PHYSICAL AND CHEMICAL PROPERTIES
Boiling point
Molecular weight
Solubility
Appearance
Flash point
Decomposition temp.
Flammability
melting point/freezing point N/A
Vapor pressure
SECTION 10
STABILITY AND REACTIVITY
Stability
Stable under normal storage and use.
Reactivity
Hazardous reactions
Conditions to avoid
Matériaux incompatible No information.
Hazardous
decomposition
SECTION 11
TOXICOLOGICAL INFORMATION
May irritate skin. Taken orally, Lithium salts can cause nausea, vomiting and abdominal pain. Central nervous system effects including slurred speech, blurred vision, dizziness, sensory loss, convulsions and stupor have been reported. Chronically, lithium effects the central nervous system, kidneys, gastrointestinal tract and causes Dermatological reactions. May cause fatigue, weight loss and thyroid disturbance. Signs of lithium poisoning are anorexia, general weakness, dehydration and dryness of the mouth Toxicity
SECTION 12
ECOLOGICAL INFORMATION
No information is found on environmental toxicity for this.
SECTION 13
DISPOSAL CONSIDERATIONS
Contact local Hazardous or Chemical waste disposal agency for regulations.
SECTION 14
TRANSPORT INFORMATION
SECTION 15
REGULATORY INFORMATION
WHMIS (Canada): WHMIS Classification C: Oxidizing Material
EC Guidelines:Safety Phrases: 36/37 - Wear suitable protective clothing, and gloves, 26 - in case of contact with eyes, rinse immediately with plenty of water and seek medical attention. 45 - in case of accident or if you feel unwell, seek medical advice immediately.
SECTION 16
OTHER INFORMATION
Reference
Creation:

Source: http://www.scancia.ca/MSDS/SCA113.pdf

Microsoft word - mohs surgery_jan10_1622.doc

Hospital contacts If you have any queries, you can contact our Mohs’ nurse coordinator via the paging system between 8.30am and 5pm, Monday to Friday. Please telephone 08448 222 888 and give the operator the pager number for the nurse you Once you have given the pager number, you will be asked to Micrographic leave a message. Please give your name and telephone number and

mandometer.com.au

PsychopharmacologyDOI 10.1007/s00213-007-1046-ySerotonin transporter binding in eating disordersPer Södersten & Cecilia BerghReceived: 28 September 2007 / Accepted: 4 December 2007A recent report suggested that patients who are in remissiona full remission, i.e., display no symptoms at discharge, runfrom an eating disorder have “divergent 5-HTT (serotonina less than 10% risk of rel

Copyright © 2011-2018 Health Abstracts